Compile Data Set for Download or QSAR
Found 53 with Last Name = 'kim' and Initial = 'iy'
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503445(CHEMBL4445544 | US11274074, Example 1 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 21nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50239465(CHEMBL4080525 | US11274074, Control [Ani9])copy SMILEScopy InChI
Affinity DataIC50: 97nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503455(CHEMBL4448175 | US11274074, Example 5 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 210nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503439(CHEMBL4515829 | US11274074, Example 6 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 300nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503434(CHEMBL4449467 | US11274074, Example 2 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 1.07E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM50503431(CHEMBL4471568 | US11274074, Example 3 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 1.24E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM542066(US11274074, Example 11 [Chemical Formula 15])copy SMILES
Affinity DataIC50: 1.31E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM542068(US11274074, Example 13 [Chemical Formula 17])copy SMILES
Affinity DataIC50: 1.42E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM542069(US11274074, Example 14 [Chemical Formula 18])copy SMILES
Affinity DataIC50: 1.48E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503440(CHEMBL4441034 | US11274074, Example 7 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 1.57E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503431(CHEMBL4471568 | US11274074, Example 3 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 1.94E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM542066(US11274074, Example 11 [Chemical Formula 15])copy SMILES
Affinity DataIC50: 2.06E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503437(CHEMBL4516441 | US11274074, Example 4 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 2.12E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503443(CHEMBL4579558 | US11274074, Example 8 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 2.57E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503449(CHEMBL4517769 | US11274074, Example 10 [Chemical F...)copy SMILEScopy InChI
Affinity DataIC50: 3.13E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM542067(US11274074, Example 12 [Chemical Formula 16])copy SMILES
Affinity DataIC50: 5.37E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM50503440(CHEMBL4441034 | US11274074, Example 7 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 5.94E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503442(CHEMBL4453660 | US11274074, Example 9 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 6.38E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503451(CHEMBL4463597 | US11274074, Comparative Example 7 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM50503451(CHEMBL4463597 | US11274074, Comparative Example 7 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503430(CHEMBL4586921 | US11274074, Comparative Example 8 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503454(CHEMBL4472630 | US11274074, Comparative Example 9[)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503444(CHEMBL4450351 | US11274074, Comparative Example 10...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503432(CHEMBL4581421 | US11274074, Comparative Example 11...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM542081(US11274074, Comparative Example 12 [Chemical Formu...)copy SMILES
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM542081(US11274074, Comparative Example 12 [Chemical Formu...)copy SMILES
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM542082(US11274074, Comparative Example 13 [Chemical Formu...)copy SMILES
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM542083(US11274074, Comparative Example 14 [Chemical Formu...)copy SMILES
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM542084(US11274074, Comparative Example 15 [Chemical Formu...)copy SMILES
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM542084(US11274074, Comparative Example 15 [Chemical Formu...)copy SMILES
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM542085(US11274074, Comparative Example 16 [Chemical Formu...)copy SMILES
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503450(CHEMBL4453183 | US11274074, Comparative Example 17...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM50503452(CHEMBL4459865 | US11274074, Comparative Example 18...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503433(CHEMBL4462374 | US11274074, Comparative Example 19...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM50503438(CHEMBL4466337 | US11274074, Comparative Example 6 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503438(CHEMBL4466337 | US11274074, Comparative Example 6 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503446(CHEMBL4434782 | US11274074, Comparative Example 5 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM50503436(CHEMBL4567262 | US11274074, Comparative Example 4 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503436(CHEMBL4567262 | US11274074, Comparative Example 4 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503447(CHEMBL4476352 | US11274074, Comparative Example 3 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM50503435(CHEMBL4465797 | US11274074, Comparative Example 2 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503435(CHEMBL4465797 | US11274074, Comparative Example 2 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM50503448(CHEMBL4470594 | US11274074, Comparative Example 1 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-1(Homo sapiens (Human))TBA
LigandPNGBDBM50503448(CHEMBL4470594 | US11274074, Comparative Example 1 ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM542069(US11274074, Example 14 [Chemical Formula 18])copy SMILES
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM542067(US11274074, Example 12 [Chemical Formula 16])copy SMILES
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM50503449(CHEMBL4517769 | US11274074, Example 10 [Chemical F...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM50503442(CHEMBL4453660 | US11274074, Example 9 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM50503439(CHEMBL4515829 | US11274074, Example 6 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
TargetAnoctamin-2(Homo sapiens)TBA
LigandPNGBDBM50503437(CHEMBL4516441 | US11274074, Example 4 [Chemical Fo...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GT5RDMUS Patent
Displayed 1 to 50 (of 53 total ) | Next | Last >>
Jump to: